Cargando…
Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
BACKGROUND: Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) syndrome are highly prevalent respiratory conditions. Their coexistence is referred to as the overlap syndrome. They are both related to pulmonary hypertension (PH) development. This study investigated the eff...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629366/ https://www.ncbi.nlm.nih.gov/pubmed/30973448 http://dx.doi.org/10.1097/CM9.0000000000000247 |
_version_ | 1783435096617910272 |
---|---|
author | Sun, Wan-Lu Wang, Jian-Li Jia, Guo-Hua Mi, Wen-Jun Liao, Yi-Xuan Huang, Yong-Wei Hu, Zheng Zhang, Li-Qiang Chen, Ya-Hong |
author_facet | Sun, Wan-Lu Wang, Jian-Li Jia, Guo-Hua Mi, Wen-Jun Liao, Yi-Xuan Huang, Yong-Wei Hu, Zheng Zhang, Li-Qiang Chen, Ya-Hong |
author_sort | Sun, Wan-Lu |
collection | PubMed |
description | BACKGROUND: Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) syndrome are highly prevalent respiratory conditions. Their coexistence is referred to as the overlap syndrome. They are both related to pulmonary hypertension (PH) development. This study investigated the effects of OSA on PH in patients with COPD and the associated factors. METHODS: Consecutive patients with stable COPD were recruited for an observational cross-sectional study from September 2016 to May 2018 at Peking University Third Hospital. In total, 106 patients with COPD were enrolled and performed home portable monitoring and echocardiography. OSA was defined by an apnea hypopnea index (AHI) ≥10 events/h. Based on OSA absence or presence, patients were divided into the COPD with OSA and COPD without OSA groups. Factors affecting pulmonary artery pressure (PAP) and PH were identified using univariate analysis and logistic regression models. RESULTS: In the 106 patients with COPD, the mean age was 69.52 years, 91.5% were men, and the mean forced expiratory volume in 1 s (FEV(1)) percentage of predicted was 56.15%. Fifty-six (52.8%) patients with COPD were diagnosed with OSA, and 24 (22.6%) patients with COPD were diagnosed as PH. Compared with COPD without OSA group, the median PAP in COPD with severe OSA group increased by 5 mmHg (36.00 [26.00–50.00] mmHg vs. 31.00 [24.00–34.00] mmHg, P = 0.036). COPD with percent of night-time spent with oxygen saturation below 90% (T90) > 10% group had higher PAP than COPD with T90 ≤ 1% group (36.00 [29.00–50.00)] mmHg vs. 29.00 [25.50–34.00] mmHg, F = 7.889, P = 0.007). Univariate analysis revealed age, FEV(1)% predicted, T90, and Charlson index had statistically significant effects on PH. Multiple regression analysis showed a significant and independent effect of both FEV(1)% predicted (odds ratio [OR] = 3.46; 95% confidence interval [CI]: 1.15–10.46; P = 0.028) and AHI (OR = 3.20; 95% CI: 1.09–19.35; P = 0.034) on PH. CONCLUSIONS: Patients with COPD with OSA are more susceptible to PH, which is associated with declining lung function and increased severity of OSA. Thus, nocturnal hypoxemia and OSA in elderly patients with COPD should be identified and treated. |
format | Online Article Text |
id | pubmed-6629366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-66293662019-07-22 Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease Sun, Wan-Lu Wang, Jian-Li Jia, Guo-Hua Mi, Wen-Jun Liao, Yi-Xuan Huang, Yong-Wei Hu, Zheng Zhang, Li-Qiang Chen, Ya-Hong Chin Med J (Engl) Original Articles BACKGROUND: Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) syndrome are highly prevalent respiratory conditions. Their coexistence is referred to as the overlap syndrome. They are both related to pulmonary hypertension (PH) development. This study investigated the effects of OSA on PH in patients with COPD and the associated factors. METHODS: Consecutive patients with stable COPD were recruited for an observational cross-sectional study from September 2016 to May 2018 at Peking University Third Hospital. In total, 106 patients with COPD were enrolled and performed home portable monitoring and echocardiography. OSA was defined by an apnea hypopnea index (AHI) ≥10 events/h. Based on OSA absence or presence, patients were divided into the COPD with OSA and COPD without OSA groups. Factors affecting pulmonary artery pressure (PAP) and PH were identified using univariate analysis and logistic regression models. RESULTS: In the 106 patients with COPD, the mean age was 69.52 years, 91.5% were men, and the mean forced expiratory volume in 1 s (FEV(1)) percentage of predicted was 56.15%. Fifty-six (52.8%) patients with COPD were diagnosed with OSA, and 24 (22.6%) patients with COPD were diagnosed as PH. Compared with COPD without OSA group, the median PAP in COPD with severe OSA group increased by 5 mmHg (36.00 [26.00–50.00] mmHg vs. 31.00 [24.00–34.00] mmHg, P = 0.036). COPD with percent of night-time spent with oxygen saturation below 90% (T90) > 10% group had higher PAP than COPD with T90 ≤ 1% group (36.00 [29.00–50.00)] mmHg vs. 29.00 [25.50–34.00] mmHg, F = 7.889, P = 0.007). Univariate analysis revealed age, FEV(1)% predicted, T90, and Charlson index had statistically significant effects on PH. Multiple regression analysis showed a significant and independent effect of both FEV(1)% predicted (odds ratio [OR] = 3.46; 95% confidence interval [CI]: 1.15–10.46; P = 0.028) and AHI (OR = 3.20; 95% CI: 1.09–19.35; P = 0.034) on PH. CONCLUSIONS: Patients with COPD with OSA are more susceptible to PH, which is associated with declining lung function and increased severity of OSA. Thus, nocturnal hypoxemia and OSA in elderly patients with COPD should be identified and treated. Wolters Kluwer Health 2019-06-05 2019-06-05 /pmc/articles/PMC6629366/ /pubmed/30973448 http://dx.doi.org/10.1097/CM9.0000000000000247 Text en Copyright © 2019 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | Original Articles Sun, Wan-Lu Wang, Jian-Li Jia, Guo-Hua Mi, Wen-Jun Liao, Yi-Xuan Huang, Yong-Wei Hu, Zheng Zhang, Li-Qiang Chen, Ya-Hong Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease |
title | Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease |
title_full | Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease |
title_fullStr | Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease |
title_full_unstemmed | Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease |
title_short | Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease |
title_sort | impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629366/ https://www.ncbi.nlm.nih.gov/pubmed/30973448 http://dx.doi.org/10.1097/CM9.0000000000000247 |
work_keys_str_mv | AT sunwanlu impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease AT wangjianli impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease AT jiaguohua impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease AT miwenjun impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease AT liaoyixuan impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease AT huangyongwei impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease AT huzheng impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease AT zhangliqiang impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease AT chenyahong impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease |